지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수1
I. 서론1. 연구의 필요성·················································12. 연구의 목적···················································43. 연구의 가설···················································44. 연구의 제한점·················································4II. 이론적 배경1. 운동과 과산화지질·············································52. 운동과 항산화 기능············································61) 항산화제 방어기전··········································62) 항산화효소의 종류··········································7(1) 슈퍼옥사이드 디스큐테이즈(superoxide dismutase; SOD)···7(2) 카탈레이즈(catalse; CAT)·······························8(3) 글루타치온 퍼록시데이즈(glutathione peroxidase; GPX)···83) 운동과 항산화 효과·········································93. 운동과 면역 기능·············································104. 블랙쵸크베리의 기능··········································11III. 연구방법1. 연구 대상····················································122. 연구기간·····················································123. 실험 방법····················································131) 실험설계 및 절차··········································142) 운동 프로그램·············································154. 측정항목 및 방법·············································161) 체격측정··················································162) 체중감량··················································163) 혈액체취 및 분석··········································165. 혈중 변인 검사···············································171) MDA 분석방법··············································172) SOD 분석방법··············································173) GPX 분석방법··············································174) 면역글로블린(lgG, lgA, lgM) 분석방법······················176. 성분 및 투여 방법············································181)실험집단(블랙쵸크베리 섭취)································182)통제집단(포도쥬스 섭취)····································187. 자료 처리····················································18IV. 연구결과1. 신체조성 변화················································192. 과산화지질(MDA)의 변화·······································233. 항산화 효소(GPX, SOD)의 변화·································264. 면역글로블린(IgG, IgA, IgM)의 변화···························30V. 논의1. 항산화제 섭취에 따른 과산화지질(MDA)의 변화··················352. 항산화제 섭취에 따른 항산화제(GPX, SOD)의 변화···············363. 항산화제 섭취에 따른 면역 글로블린(IgG, IgA, IgM)의 변화·····38VI. 결론 및 제언1. 결론·························································402. 제언·························································40참고문헌····························································42
0